Assays for short sequence variants

• US 7,662,550 B1
• Filed: 10/13/2000
• Issued: 02/16/2010
• Est. Priority Date: 10/22/1999
• Status: Expired due to Term

• Current Assignee: The Public Health Research Institute of the City of New York, Inc.
• Original Assignee: PHRI Properties, Inc.
• Inventors: Alland, David, Kramer, Fred R., Tyagi, Sanjay
• Primary Examiner(s): Horlick; Kenneth R.
• Assistant Examiner(s): Tung; Joyce
• Application Number:
  US10/110,907
• Time in Patent Office: 3,413 Days
• Field of Search: 435/6, 435/91.2, 536/24.3, 536/25.32, 536/26.6
• US Class Current: 435/6.18
• CPC Class Codes: C12Q 1/6818 involving interaction of two or more labels, e.g. resonant energy transfer
• CPC Class Codes: C12Q 1/689 for bacteria
• CPC Class Codes: C12Q 2525/301 Hairpin oligonucleotides

Abstract

The invention provides assays that can detect multiple genetic variants of a gene (e.g., a mycobacterial gene) in a sample using a pool (e.g., 2, 3, 4, or more) of oligonucleotide hybridization probes.

Claims

1. A homogeneous detection assay method for identifying which variant among multiple variants of a short nucleotide sequence is present in a sample, said multiple variants differing from one another by one or more changes selected from the group of nucleotide substitutions, deletions and additions, comprising:

(a) providing a reaction mixture containing the sample with at least three hybridization probes having different target binding sequences, said probes being capable of hybridizing to mismatched targets in the assay, and said probes being differently fluorescently labeled probes whose hybridization can be detected without separating unbound probes, wherein each of said probes is capable of hybridizing to more than one variant of said multiple variants with varying degrees of complementarity;

(b) measuring the intensity of fluorescence signals resulting from hybridization of each of said probes; and

(c) identifying which variant is present by determining a fluorescence fingerprint for the sample, said fluorescence fingerprint comprising ratios of the intensities of the fluorescence signals of the at least three probes.

2. The method of claim 1, wherein said reaction mixture is an amplification reaction mixture, the method further comprising, after forming said amplification reaction mixture containing said probes, amplifying said short nucleotide sequence.

3. The method of claim 2, wherein said amplification reaction mixture is a PCR amplification mixture that includes a primer pair and a DNA polymerase.

4. The method of claim 3, wherein said DNA polymerase possesses exonucleolytic or endonucleolytic activity and wherein said hybridization probes are cleavable during said PCR amplification by said polymerase when hybridized to said short nucleotide sequence.

5. The method of claim 3, wherein each of the last three probes has a single-stranded loop target-binding sequence of 25-50 nucleotides in length and an arms hybrid.

6. The method of claim 5, wherein said probes are constructed from modified nucleotides.

7. The method of claim 1, wherein each of said probes has a single-stranded loop target-binding sequence of 25-50 nucleotides in length and an arms hybrid.

8. The method of claim 7, wherein said short nucleotide sequence has a length of up to about fifty nucleotides.

9. The method of claim 7, wherein said short nucleotide sequence is a gene sequence.

10. The method of claim 7, wherein said probes are immobilized at preselected locations on a solid surface.

11. The method of claim 7, wherein said short nucleotide sequence is a mammalian gene.

12. The method of claim 7, wherein said short nucleotide sequence is a microbial gene.

13. The method of claim 12, wherein said microbial gene is a bacterial gene.

14. The method of claim 13, wherein said bacterial gene is a mycobacterial gene.

15. The method of claim 11, wherein said gene is an oncogene.

16. The method of claim 11, wherein said gene is associated with a metabolic disease.

17. The method of claim 11, wherein said gene is associated with an autoimmune disease.